Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hypertension
  Free Subscription

22.09.2025

1 Circ Genom Precis Med
2 Circ Heart Fail
2 Circulation
1 Clin Exp Hypertens
1 Eur J Pharmacol
14 Hypertension
1 J Hum Hypertens
7 JAMA
1 PLoS Med
3 PLoS One


    Circ Genom Precis Med

  1. BHATTACHARYA R, Marnell CS, Cho SMJ, Patel AP, et al
    Importance of Clinical, Laboratory, and Genetic Risk Factors for Incident CAD.
    Circ Genom Precis Med. 2025;18:e004937.
    >> Share


    Circ Heart Fail

  2. BADAGLIACCA R, Tello K, D'Alto M, Ghio S, et al
    TAPSE/sPAP Ratio to Improve Risk Assessment in Pulmonary Arterial Hypertension.
    Circ Heart Fail. 2025 Sep 17:e012518. doi: 10.1161/CIRCHEARTFAILURE.124.012518.
    >> Share

  3. HUNGERFORD SL, Everett K, Lau E, Burkhoff D, et al
    Pulmonary Circulation in Advanced Heart Failure and Cardiogenic Shock: State-of-the-Art Review.
    Circ Heart Fail. 2025 Jun 2:e012611. doi: 10.1161/CIRCHEARTFAILURE.124.012611.
    >> Share


    Circulation

  4. KHAN SS, Abdalla M, Bello NA, Blyler CA, et al
    Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2025 Aug 28. doi: 10.1161/CIR.0000000000001355.
    >> Share

  5. JONES DW, Ferdinand KC, Taler SJ, Johnson HM, et al
    2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Commit
    Circulation. 2025;152:e114-e218.
    >> Share


    Clin Exp Hypertens

  6. SUN Z, Dai G, Quan N
    Hypertension accelerates aging: Evidence from NHANES database and Mendelian randomization analyses.
    Clin Exp Hypertens. 2025;47:2559743.
    >> Share


    Eur J Pharmacol

  7. CHANDHRU M, Ramamurthy K, Sudhakaran G, Choi KC, et al
    Aging-related epigenetic instability in lncRNAs and miRNAs mediates the development of hypertension.
    Eur J Pharmacol. 2025 Sep 12:178150. doi: 10.1016/j.ejphar.2025.178150.
    >> Share


    Hypertension

  8. MANDAL J, Aryal S, Manandhar I, Chakraborty S, et al
    Epigenetic Histone beta-Hydroxybutyrylation Contributes to Renoprotection by beta-Hydroxybutyrate in the Dahl Rat.
    Hypertension. 2025;82:1729-1742.
    >> Share

  9. COSTELLO HM, Grenier C, Ivy JR, Czopek A, et al
    Chronic ACTH Infusion Alters the Diurnal Rhythm of Sodium Excretion, Inducing Nondipping Blood Pressure and Salt-Sensitivity in Male Mice.
    Hypertension. 2025;82:1754-1766.
    >> Share

  10. CHEN X, Kimura H, Sasaki T, Klimek K, et al
    Redefining AT1 Receptor PET Imaging: Introducing the Radiotracer [(18)F]DR29.
    Hypertension. 2025;82:1626-1637.
    >> Share

  11. JONES DW, Ferdinand KC, Taler SJ, Johnson HM, et al
    2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Commit
    Hypertension. 2025;82:e212-e316.
    >> Share

  12. AKINS JD, Richey RE, Martin ZT, Fadel PJ, et al
    Mechanisms of Elevated Cutaneous Vascular Tone in College-Aged Black Individuals.
    Hypertension. 2025;82:1675-1686.
    >> Share

  13. NENE A, Lee D, Agboola O, Herrin J, et al
    Evaluating Blood Pressure Response Patterns to Exercise Stress Testing.
    Hypertension. 2025;82:1663-1674.
    >> Share

  14. LAUDER L, Rahimi K, Bohm M, Mahfoud F, et al
    Debate on the 2025 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: New Blood Pressure Targets, Lower Is Better-And Possible.
    Hypertension. 2025;82:1551-1558.
    >> Share

  15. TOWNSEND RR
    Debate on the 2025 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Emphasis on Defense Against the BP Threshold and Why We May Not Get There Easily.
    Hypertension. 2025;82:1559-1568.
    >> Share

  16. KHAN SS, Abdalla M, Bello NA, Blyler CA, et al
    Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Hypertension. 2025 Aug 28. doi: 10.1161/HYP.0000000000000248.
    >> Share

  17. TANG J, Xiao D, Yang S, Fang L, et al
    sFlt-1/PlGF Ratio Predicts Short-Term Maternal-Fetal Outcomes in Chinese Hypertensive Pregnancies: A Prospective Cohort Study.
    Hypertension. 2025 Sep 15. doi: 10.1161/HYPERTENSIONAHA.125.25022.
    >> Share

  18. ZHANG X, Yang B, Li M, Guo X, et al
    Prenatal PM(2.5) Exposure Induces Offspring Hypertension via Nrf2/NLRP3 Pathway.
    Hypertension. 2025 Sep 16. doi: 10.1161/HYPERTENSIONAHA.125.24874.
    >> Share

  19. RONG WW, Yang YH, Deng QW, Chen XH, et al
    Targeting IL-16 to Protect Angiotensin II-induced Hypertension and Renal Injury.
    Hypertension. 2025 Sep 16. doi: 10.1161/HYPERTENSIONAHA.125.25172.
    >> Share

  20. HUNDEMER GL, Goupil R
    Implementing the 2025 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: How to Translate Team-Based Care of Hypertension to the Real World.
    Hypertension. 2025;82:1535-1537.
    >> Share

  21. HARRISON DG, Touyz RM
    Hypertension Editors' View of the 2025 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.
    Hypertension. 2025;82:e193-e195.
    >> Share


    J Hum Hypertens

  22. SABAN MT, Tootooni S, Markossian TW, Wozniak A, et al
    The association of area deprivation index and blood pressure control and therapeutic inertia among older adults with hypertension.
    J Hum Hypertens. 2025 Sep 16. doi: 10.1038/s41371-025-01067.
    >> Share


    JAMA

  23. BROOK RD, Cohen JB, Rajagopalan S
    Medications for Resistant Hypertension-Reply.
    JAMA. 2025 Sep 15. doi: 10.1001/jama.2025.12656.
    >> Share

  24. XU Q, Gao Y, Zhang O
    Medications for Resistant Hypertension.
    JAMA. 2025 Sep 15. doi: 10.1001/jama.2025.12653.
    >> Share

  25. FENG S, Li H, Sun R
    Timing of Antihypertensive Medications and Cardiovascular Outcomes.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12793.
    >> Share

  26. CEDERNAES J, Benedict C
    Timing of Antihypertensive Medications and Cardiovascular Outcomes.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12784.
    >> Share

  27. GARRISON SR, Kolber MR, Korownyk CS
    Timing of Antihypertensive Medications and Cardiovascular Outcomes-Reply.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12796.
    >> Share

  28. GAO M, Cao T, Wu Q
    Timing of Antihypertensive Medications and Cardiovascular Outcomes.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12787.
    >> Share

  29. ZHU J, Zhang W
    Timing of Antihypertensive Medications and Cardiovascular Outcomes.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12790.
    >> Share


    PLoS Med

  30. FUJIWARA T, Koshiaris C, Cai T, Wang A, et al
    Associations between falls and other serious adverse events and antihypertensive medication in individuals with dementia: An observational cohort study.
    PLoS Med. 2025;22:e1004731.
    >> Share


    PLoS One

  31. MORALES-GARZON S, Vasconez J, Delgado JP, Barrera-Guarderas F, et al
    The burden of non-communicable disease risk factors in a low-income population: Findings from a cross-sectional study highlighting the prevalence of obesity, hypertension, and metabolic disorders in the south of Quito, Ecuador.
    PLoS One. 2025;20:e0332159.
    >> Share

  32. MICHALEC J, Lustigova M, Fruhaufova A, Mala S, et al
    Prevalence and clustering of cardiovascular risk factors in a population aged 25-64 in Czechia: A cross-sectional study.
    PLoS One. 2025;20:e0332217.
    >> Share

  33. HOLDBROOKE SJ, Afolabi BM
    Predictive ability of plasma concentration of triglyceride/high density lipoprotein-cholesterol ratio for cardiometabolic variables in a sub-Sahara black African adolescent population-Nigerians.
    PLoS One. 2025;20:e0322266.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016